Ngā hua rapu - Robert Flisiak

Whakamahine hua
  1. 1
    Role of cannabinoids in chronic liver diseases

    Role of cannabinoids in chronic liver diseases mā Anna Parfieniuk‐Kowerda, Robert Flisiak

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Thrombotic Thrombocytopenia after COVID-19 Vaccination: In Search of the Underlying Mechanism

    Thrombotic Thrombocytopenia after COVID-19 Vaccination: In Search of the Underlying Mechanism mā Piotr Rzymski, Bartłomiej Perek, Robert Flisiak

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Effect of interferon alpha2b plus ribavirin treatment on selected growth factors in respect to inflammation and fibrosis in chronic hepatitis C

    Effect of interferon alpha2b plus ribavirin treatment on selected growth factors in respect to inflammation and fibrosis in chronic hepatitis C mā Anatol, Panasiuk, Robert, Flisiak, Danuta, Prokopowicz

    I whakaputaina 2005
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Hepatitis C: efficacy and safety in real life

    Hepatitis C: efficacy and safety in real life mā Robert Flisiak, Joanna Pogorzelska, Marta Flisiak‐Jackiewicz

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    The Role of Th17 Response in COVID-19

    The Role of Th17 Response in COVID-19 mā Diana Martonik, Anna Parfieniuk‐Kowerda, Magdalena Rogalska, Robert Flisiak

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins

    The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins mā Lech Chrostek, Łukasz Supronowicz, Anatol Panasiuk, Bogdan Cylwik, Ewa Gruszewska, Robert Flisiak

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Helicobacter pylori infection among patients with liver cirrhosis

    Helicobacter pylori infection among patients with liver cirrhosis mā Joanna Pogorzelska, Magda Łapińska, Alicja Kalinowska-Łyszczarz, Tadeusz Wojciech Łapiński, Robert Flisiak

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C

    Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C mā Michał Brzdęk, Dorota Zarębska‐Michaluk, Federica Invernizzi, Marta Cilla, Krystyna Dobrowolska, Robert Flisiak

    I whakaputaina 2023
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Recommendations for the treatment of hepatitis C in 2017

    Recommendations for the treatment of hepatitis C in 2017 mā Waldemar Halota, Robert Flisiak, Jacek Juszczyk, Piotr Małkowski, Małgorzata Pawłowska, Krzysztof Simon, Krzysztof Tomasiewicz

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Like a Rolling Stone? A Review on Spontaneous Clearance of Hepatitis C Virus Infection

    Like a Rolling Stone? A Review on Spontaneous Clearance of Hepatitis C Virus Infection mā Piotr Rzymski, Michał Brzdęk, Krystyna Dobrowolska, Barbara Poniedziałek, Aleksandra Murawska-Ochab, Dorota Zarębska‐Michaluk, Robert Flisiak

    I whakaputaina 2024
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Hyaluronic acid concentration in liver diseases

    Hyaluronic acid concentration in liver diseases mā Monika Gudowska-Sawczuk, Ewa Gruszewska, Anatol Panasiuk, Bogdan Cylwik, Robert Flisiak, Magdalena Świderska, Maciej Szmitkowski, Lech Chrostek

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2023

    Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2023 mā Krzysztof Tomasiewicz, Robert Flisiak, Jerzy Jaroszewicz, Piotr Małkowski, Małgorzata Pawłowska, Anna Piekarska, Krzysztof Simon, Dorota Zarębska‐Michaluk

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C

    A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C mā Robert Flisiak, Mitchell L. Shiffman, Juan Arenas, Hugo Cheinquer, И. Г. Никитин, Yuping Dong, Khurram Rana, Subasree Srinivasan

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Recommendations of management in SARS-CoV-2 infection of the Polish Association of Epidemiologists and Infectiologists

    Recommendations of management in SARS-CoV-2 infection of the Polish Association of Epidemiologists and Infectiologists mā Robert Flisiak, Andrzej Horban, Jerzy Jaroszewicz, Dorota Kozielewicz, Małgorzata Pawłowska, Miłosz Parczewski, Anna Piekarska, Krzysztof Tomasiewicz, Dorota Zarębska‐Michaluk

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 2 as of October 13, 2020

    Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 2 as of October 13, 2020 mā Robert Flisiak, Miłosz Parczewski, Andrzej Horban, Jerzy Jaroszewicz, Dorota Kozielewicz, Małgorzata Pawłowska, Anna Piekarska, Krzysztof Simon, Krzysztof Tomasiewicz, Dorota Zarębska‐Michaluk

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Clinical Characteristics of Hospitalized COVID-19 Patients Who Received at Least One Dose of COVID-19 Vaccine

    Clinical Characteristics of Hospitalized COVID-19 Patients Who Received at Least One Dose of COVID-19 Vaccine mā Piotr Rzymski, Monika Pazgan‐Simon, Krzysztof Simon, Tadeusz Wojciech Łapiński, Dorota Zarębska‐Michaluk, Barbara Szczepańska, Michał Chojnicki, Iwona Mozer‐Lisewska, Robert Flisiak

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Acylcarnitine and Free Fatty Acid Profiles in Primary Biliary Cholangitis: Associations with Fibrosis and Inflammation

    Acylcarnitine and Free Fatty Acid Profiles in Primary Biliary Cholangitis: Associations with Fibrosis and Inflammation mā Magdalena Rogalska, Agnieszka Błachnio‐Zabielska, Piotr Zabielski, J Janica, Kamila Roszczyc-Owsiejczuk, Karolina Pogodzińska, Aleksandra Andrzejuk, A Dâbrowski, Robert Flisiak, Paweł Rogalski

    I whakaputaina 2025
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe

    Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe mā Vincent Soriano, Amanda Mocroft, Lars Peters, JK Rockstroh, Francisco Antunes, Nikolai Kirkby, Stéphane De Wit, A. D’Arminio Monforte, Robert Flisiak, Jens Lundgren

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Management of SARS-CoV-2 Infection-Clinical Practice Guidelines of the Polish Association of Epidemiologists and Infectiologists, for 2025

    Management of SARS-CoV-2 Infection-Clinical Practice Guidelines of the Polish Association of Epidemiologists and Infectiologists, for 2025 mā Robert Flisiak, Jerzy Jaroszewicz, Dorota Kozielewicz, Ernest Kuchar, Miłosz Parczewski, Małgorzata Pawłowska, Anna Piekarska, Piotr Rzymski, Krzysztof Simon, Krzysztof Tomasiewicz, Dorota Zarębska‐Michaluk

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Real‐world effectiveness of ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in patients with hepatitis C virus genotype 1 or 4 infection: A meta‐analysis

    Real‐world effectiveness of ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in patients with hepatitis C virus genotype 1 or 4 infection: A meta‐analysis mā Heiner Wedemeyer, Antonio Craxı̀, E. Zuckerman, Douglas T. Dieterich, Robert Flisiak, Stuart K. Roberts, Andreas Pangerl, Z. Zhang, Marisol Martínez, Yanjun Bao, José Luís Calleja

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: